Theodore Witek

Theodore J.
Witek is currently the Chairman at Molecular Science Corp.
He is also the Director at Trudell Medical Ltd., Independent Non-Executive Director at AFT Pharmaceuticals Ltd., Director at Ontario Health Innovation Council, Special Advisor at Lumira Capital Investment Management, Inc., Professor at Dalla Lana School of Public Health, and Professor at Leslie Dan Faculty of Pharmacy.
In the past, Dr. Witek served as the President & Chief Executive Officer at Boehringer Ingelheim Ltda.
from 1992 to 2008, and at Boehringer Ingelheim (Canada) Ltd.
from 1992 to 2014.
He was also the Chairman at American Thoracic Society, Inc. from 2010 to 2012, and held positions as Chairman at Ehave, Inc., Independent Director at Helix BioPharma Corp., and Director at Innovative Medicines Canada.
Additionally, he served as the Senior Vice President-Clinical & Medical Affairs at Innoviva, Inc. from 2014 to 2018.
Dr. Witek holds a doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from Yale University, and an MBA from Henley Management College.